Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+57.9%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+57.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
3.9x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$35.58M+370.2%
2024$7.57M+47.7%
2023$5.12M-43.3%
2022$9.03M-24.7%
2021$12.00M-
2020$0.00-
2019$0.00-
2018$0.00-
2017$0.00-
2016$0.00-